6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine
C40H51ClF4N14S2 — CID 161288578
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine
6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine (PubChem CID 161288578) has the molecular formula C40H51ClF4N14S2 and a molecular weight of 903.52 g/mol. Its IUPAC name is 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine.
Molecular Properties
| Compound Name | 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine |
|---|---|
| PubChem CID | 161288578 |
| Molecular Formula | C40H51ClF4N14S2 |
| Molecular Weight | 903.52 g/mol |
| Exact Mass | 902.35 |
| IUPAC Name | 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethylpyrazol-1-yl)-4-N-[1-(1,3-thiazol-2-yl)ethyl]pyrimidine-4,6-diamine;1-(1,3-thiazol-2-yl)ethanamine |
| SMILES | CC(N)c1nccs1.Cc1cc(C)n(-c2nc(Cl)cc(NC3CCC(F)(F)CC3)n2)n1.Cc1cc(C)n(-c2nc(NC3CCC(F)(F)CC3)cc(NC(C)c3nccs3)n2)n1 |
| InChI | InChI=1S/C20H25F2N7S.C15H18ClF2N5.C5H8N2S/c1-12-10-13(2)29(28-12)19-26-16(24-14(3)18-23-8-9-30-18)11-17(27-19)25-15-4-6-20(21,22)7-5-15;1-9-7-10(2)23(22-9)14-20-12(16)8-13(21-14)19-11-3-5-15(17,18)6-4-11;1-4(6)5-7-2-3-8-5/h8-11,14-15H,4-7H2,1-3H3,(H2,24,25,26,27);7-8,11H,3-6H2,1-2H3,(H,19,20,21);2-4H,6H2,1H3 |
| InChIKey | VGAXMKRPCKXCTC-UHFFFAOYSA-N |
| XLogP | 9.98 |
| TPSA | 175.09 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 903.52 |
| LogP ≤ 5 | 9.98 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161288578 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.